researchbuprenorphinematBronx Hospitals Screened 9,140 Patients for Addiction Care. 23 Started Treatment.Two Bronx teaching hospitals built an algorithm to find hospitalized patients who could benefit from buprenorphine. Over two years it flagged 9,140 records and 23 people started the medication — a 5 percent yield that shows how much of hospital addiction care still rests on manual chart review and patient willingness.October 8, 20267 min read
researchmatbuprenorphineOnly 3% of Young Patients Stay on Addiction MedicationEight years of national Medicaid claims show where young people with opioid use disorder drop out of care: half never start treatment, most never receive medication, and fewer than one in 30 is still taking it six months later. The findings arrive as New York, home to one of the country's largest Medicaid programs, prepares for federal changes that could push more patients out of care.October 5, 20267 min read
newsresearchmental-healthWhy Menopause Is Becoming a Critical Factor in Addiction Treatment—and Why Most Programs Ignore ItFederal health officials are warning that menopause may be an overlooked trigger for substance use disorders in women, with new research linking hormonal shifts to increased drinking and relapse risk.May 25, 20266 min read
researchtreatmentmatYale Study Establishes First Expert Consensus on Hospital Addiction Treatment in the Fentanyl EraYale researchers used the Delphi method to develop clinical consensus on hospital-initiated medications for opioid use disorder, addressing rapid methadone protocols and high-dose buprenorphine strategies for patients using high-potency synthetic opioids.May 15, 20266 min read
newstreatmentresearchFDA Fast-Tracks Psychedelic Therapies for Depression, PTSD, and Alcohol Use Disorder—What It Means for New YorkThe FDA announced sweeping actions to accelerate psychedelic treatments, including priority vouchers for psilocybin and methylone, plus the first-ever U.S. clinical trial of an ibogaine derivative for alcohol use disorder.April 27, 20266 min read
newsresearchtreatmentFeds Launch $139 Million Project to Transform Addiction Treatment—And It Could Change How New Yorkers Get CareA new federal initiative aims to end the trial-and-error approach to mental health and addiction treatment by developing objective, measurable biomarkers—potentially bringing faster relief to millions of Americans, including those in New York.April 22, 20266 min read
researchtobaccomental-healthWhy Smoking Keeps Getting Ignored in Addiction Treatment—and What a New Study RevealsA longitudinal study of nearly 5,000 mothers finds that poverty and mental health—not smoking itself—drive the link between cigarettes and food insecurity, highlighting systemic gaps in addiction treatment.April 18, 20266 min read
researchtreatmentoverdoseFederal Study Shows Ozempic and Weight-Loss Drugs Cut Addiction Deaths by Half—What It Means for New YorkFederal researchers report the first medication that works against addiction to alcohol, opioids, nicotine, cocaine and cannabis simultaneously. The unexpected finding came from diabetes and weight-loss drugs already prescribed to millions.March 18, 20268 min read
opioidfentanyloverdoseFederal Lab Develops New Drug That Could Cut Fentanyl Overdose Recovery Time in HalfLawrence Livermore National Laboratory researchers have developed subetadex, a new compound that cuts fentanyl overdose recovery time from 35 to 17 minutes and remains active in the body for 7.5 hours — compared to Narcan's 30-80 minutes.March 3, 20268 min read
